Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
13 studies found for:    18287387 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
Conditions: Multiple Myeloma;   Leukemia, Plasma Cell
Interventions: Drug: Carfilzomib;   Drug: Melphalan;   Drug: Filgrastim
2 Active, not recruiting Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
Conditions: Oral Squamous Cell Carcinoma (OSCC);   Oral Epithelial Dysplasia
Interventions: Drug: Bioadhesive 10% freeze-dried black raspberry gel;   Drug: Color/consistency matched placebo gel
3 Completed A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening
Conditions: Cervical Intraepithelial Neoplasia;   Human Papillomavirus
Intervention:
4 Recruiting Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Procedure: Adoptive Immunotherapy;   Biological: Rapamycin-Generated Autologous Th1/Tc1 Cells
5 Active, not recruiting Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms;   Head and Neck Neoplasms;   Tongue Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Sirolimus
6 Active, not recruiting Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small-Cell Lung
Intervention:
7 Unknown  INDUCTION CHEMOTHERAPY FOLLOWED BY CETUXIMAB AND RADIATION THERAPY FOR HEAD AND NECK CANCER
Condition: Head and Neck Cancer
Interventions: Radiation: Radiotherapy;   Drug: Leucovorin;   Biological: Cetuximab;   Drug: Filgrastim;   Drug: Erythropoetin;   Drug: Cisplatin;   Drug: Fluorouracil;   Drug: Docetaxel
8 Completed Anal Cancer Screening Study
Condition: Anal Cancer
Intervention:
9 Completed EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration
Conditions: Pancreas Adenocarcinoma;   Pancreas Neoplasms;   Gastrointestinal Stromal Tumor;   Lymphoma
Interventions: Device: Fine needle biopsy using ProCore needle for histology.;   Device: Fine needle aspiration using conventional FNA for cytology
10 Withdrawn Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
Conditions: Colorectal Carcinoma;   Peritoneal Carcinomatosis
Intervention: Procedure: Laparotomy+ HIPEC +/- CRS
11 Completed
Has Results
Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasms
Intervention: Drug: Pegylated L-Asparaginase
12 Recruiting A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
Conditions: Head and Neck Neoplasms;   Lung Neoplasms;   Urinary Bladder Neoplasms;   Breast Neoplasms
Interventions: Drug: 5-Fluoro-2-Deoxycytidine (FdCyd);   Drug: Tetrahydrouridine (THU)
13 Recruiting Collection of Transplant Stem Cells for Plasma Cell Myeloma
Conditions: Plasma Cell Myeloma;   Multiple Myeloma
Interventions: Drug: Filgrastim;   Drug: Plerixafor;   Procedure: Apheresis

Indicates status has not been verified in more than two years